Related Experiment Video
Updated: Aug 5, 2026

Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
Published on: October 13, 2023
Development of a one-step office hysteroscopic lightweight artificial intelligence application for subfertility risk
Bohan Li1, Hui Chen2,3, Hua Duan1
1Department of Minimally Invasive Gynecologic Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China.
Abstract:
Intrauterine adhesions (IUAs) pose challenges to natural fertility and impede timely conception. Assisted reproductive technologies (ART) offer effective solutions but are often expensive in developing nations. This study introduces an artificial intelligence (AI) application, MobilenetV3PH, featuring a proportional hazard (PH) neural network architecture to predict reproductive outcomes following hysteroscopic adhesiolysis in IUAs and to categorize subfertility risks. The present study leveraged 4922 second-look hysteroscopic images obtained from 555 patients post-hysteroscopic adhesiolysis, sourced from a prospective IUA clinical database (NCT05381376). The prospective cohort was randomly partitioned into training, validation, and test sets for model development, hyperparameter validation, and external validation. MobilenetV3PH achieved a noteworthy Area Under the Curve (AUC) of 0.920, outperforming alternative models significantly. The AI application seamlessly integrated into the hysteroscopic platform, demonstrating an average analysis time of 35.7 ± 5.6 s per patient. Notably, it excelled in predicting natural conception compared to conventional clinical scoring methods. The identification of high-risk IUAs patients who encounter difficulties in natural conception through AI-predicted subfertility risks revealed that these individuals might derive greater benefits from ART (HR = 4.616, P = 0.007) compared to their low-risk counterparts (HR = 0.628, P = 0.534). Overall, this AI tool exhibits promise for practical clinical applications, assisting in the prediction of postoperative difficulties in natural conception, patient risk stratification, and management strategies making, ultimately enhancing cost-effective interventions.

